Aevi Genomic Medicine, LLC

CIK 1138776 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aevi Genomic Medicine, LLC.

Recent SEC filings

FiledFormAccession number
Jun 11, 202040001192482-20-000475
Feb 14, 2020SC 13G/A0001104659-20-021762
Feb 14, 202015-12B0001104659-20-021056
Feb 13, 2020EFFECT9999999995-20-000340
Feb 13, 2020EFFECT9999999995-20-000341
Feb 13, 2020EFFECT9999999995-20-000339
Feb 12, 2020POS AM0001104659-20-019154
Feb 12, 2020S-8 POS0001104659-20-019161
Feb 12, 2020POS AM0001104659-20-019152
Feb 12, 2020S-8 POS0001104659-20-019165
Feb 12, 2020SC 13G/A0000902664-20-000966
Feb 12, 2020POS AM0001104659-20-019155
Feb 12, 2020S-8 POS0001104659-20-019169
Feb 12, 2020S-8 POS0001104659-20-019159
Feb 12, 2020RW0001104659-20-019150
Feb 12, 2020S-8 POS0001104659-20-019166
Feb 12, 2020S-8 POS0001104659-20-019168
Feb 12, 2020S-8 POS0001104659-20-019163
Feb 7, 202030001104659-20-012389
Feb 7, 2020SC 13D0001104659-20-012387
Feb 7, 202040001104659-20-012390
Feb 5, 202040001192482-20-000113
Feb 5, 202040001192482-20-000115
Feb 5, 202040001192482-20-000111
Feb 5, 202040001192482-20-000123